Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,461Revenue (TTM) $M533Net Margin (%)-10.6Altman Z-Score31.5
Enterprise Value $M5,385EPS (TTM) $-0.7Operating Margin %-10.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.3Pre-tax Margin (%)-10.6Higher ROA y-yY
Price/Book21.010-y EBITDA Growth Rate %-17.7Quick Ratio2.5Cash flow > EarningsY
Price/Sales10.15-y EBITDA Growth Rate %-15.7Current Ratio3.0Lower Leverage y-yN
Price/Free Cash Flow1,303y-y EBITDA Growth Rate %--ROA % (ttm)-18.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-24.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M84.5ROIC % (ttm)-47.6Gross Margin Increase y-yN

Gurus Latest Trades with DXCM

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DXCMJohn Paulson 2016-09-30 Reduce-0.06%$77.55 - $95.8
($89.02)
$ 64.61-27%Reduce -64.78%43,500
DXCMRon Baron 2016-09-30 Reduce-0.02%$77.55 - $95.8
($89.02)
$ 64.61-27%Reduce -5.57%851,477
DXCMGeorge Soros 2016-09-30 Buy 0.01%$77.55 - $95.8
($89.02)
$ 64.61-27%New holding2,576
DXCMMario Gabelli 2016-09-30 Reduce$77.55 - $95.8
($89.02)
$ 64.61-27%Reduce -0.72%41,600
DXCMRon Baron 2016-06-30 Reduce-0.07%$60.63 - $79.33
($68.1)
$ 64.61-5%Reduce -17.46%901,677
DXCMJohn Paulson 2016-06-30 Add0.07%$60.63 - $79.33
($68.1)
$ 64.61-5%Add 199.03%123,500
DXCMMario Gabelli 2016-06-30 Reduce$60.63 - $79.33
($68.1)
$ 64.61-5%Reduce -3.46%41,900
DXCMJohn Paulson 2016-03-31 Buy 0.02%$53.38 - $81.9
($66.94)
$ 64.61-3%New holding41,300
DXCMGeorge Soros 2016-03-31 Sold Out -0.01%$53.38 - $81.9
($66.94)
$ 64.61-3%Sold Out0
DXCMMario Gabelli 2016-03-31 Reduce$53.38 - $81.9
($66.94)
$ 64.61-3%Reduce -2.25%43,400
DXCMRon Baron 2016-03-31 Add$53.38 - $81.9
($66.94)
$ 64.61-3%Add 0.18%1,092,441
DXCMRon Baron 2015-12-31 Reduce-0.09%$70.65 - $88.83
($83.22)
$ 64.61-22%Reduce -18.06%1,090,473
DXCMGeorge Soros 2015-12-31 Buy 0.01%$70.65 - $88.83
($83.22)
$ 64.61-22%New holding5,700
DXCMMario Gabelli 2015-12-31 Reduce$70.65 - $88.83
($83.22)
$ 64.61-22%Reduce -2.20%44,400
DXCMRon Baron 2015-09-30 Reduce$79.36 - $101.91
($89.24)
$ 64.61-28%Reduce -0.51%1,330,742
DXCMMario Gabelli 2015-09-30 Reduce$79.36 - $101.91
($89.24)
$ 64.61-28%Reduce -10.63%45,400
DXCMRon Baron 2015-06-30 Reduce$61.49 - $79.98
($70.13)
$ 64.61-8%Reduce -0.06%1,337,607
DXCMJoel Greenblatt 2015-03-31 Sold Out -0.0044%$54.21 - $64.42
($60.43)
$ 64.617%Sold Out0
DXCMRon Baron 2015-03-31 Reduce$54.21 - $64.42
($60.43)
$ 64.617%Reduce -0.17%1,338,407
DXCMMario Gabelli 2015-03-31 Reduce$54.21 - $64.42
($60.43)
$ 64.617%Reduce -1.55%50,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DXCM is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DXCM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DOUBLEDAY RICHARDEVP, Chief Commercial Officer 2016-11-23Sell3,182$70.19-7.95view
Pacelli Steven RobertEVP, Strategy & Corp. Dev. 2016-11-23Sell10,300$70.32-8.12view
LISTER JOHNGeneral Manager, EMEA 2016-11-09Sell3,417$62.53.38view
ROPER JESSSVP, CFO 2016-10-24Sell2,471$80.75-19.99view
Pacelli Steven RobertEVP, Strategy & Corp. Dev. 2016-10-24Sell10,300$81.95-21.16view
DOUBLEDAY RICHARDEVP, Chief Commercial Officer 2016-10-24Sell3,182$81.12-20.35view
Balo Andrew KEVP, Clinical and Regulatory 2016-10-19Sell4,997$82.31-21.5view
SAYER KEVIN RPresident & CEO 2016-10-14Sell7,000$81.87-21.08view
LISTER JOHNGeneral Manager, EMEA 2016-10-10Sell3,560$84.41-23.46view
VALDES JORGE ACTO 2016-10-10Sell11,000$84.42-23.47view

Quarterly/Annual Reports about DXCM:

News about DXCM:

Articles On GuruFocus.com
Weekly CFO Sells Highlight Jun 28 2016 
Baron Funds Comments on DexCom Inc. Jan 14 2016 
Investing for Lower Risk Long-Term Growth in a Volatile Asset Class - Baron Funds Winter Newsletter Jan 14 2016 
Top Weekly Insider Sells Highlights Sep 15 2015 
Weekly CFO Sells Highlight: Gilead Sciences, DexCom, and Palo Alto Networks Sep 13 2015 
Panic-Proofing the Small Investor Aug 26 2015 
Baron Funds Comments on DexCom Inc. Aug 19 2015 
Weekly CFO Sells Highlight: Cigna Corp, Comcast Corp, and DexCom Inc. Jul 20 2015 
Weekly Insider Sells Highlight: GILD, AXTA, GME, DXCM Jul 14 2015 
Weekly CFO Sells Highlight: Axalta Coating Systems Ltd, Palo Alto Networks Inc, DexCom Inc. Jul 13 2015 

More From Other Websites
DEXCOM INC Files SEC form 8-K, Change in Directors or Principal Officers Dec 08 2016
Is DexCom, Inc. (DXCM) A Good Stock To Buy? Dec 01 2016
6 stocks to watch Dec 01 2016
Johnson & Johnson (JNJ), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Experts at March Altus Like... Nov 15 2016
DexCom Announces Upcoming Conference Presentation Nov 15 2016
DexCom Announces Upcoming Conference Presentation Nov 15 2016
With Health Canada approval, Dexcom G5® Mobile CGM System is the First and Only Medical Device in... Nov 14 2016
With Health Canada approval, Dexcom G5® Mobile CGM System is the First and Only Medical Device in... Nov 14 2016
With Health Canada approval, Dexcom G5® Mobile CGM System is the First and Only Medical Device in... Nov 14 2016
NIH-funded International Diabetes Closed Loop (IDCL) Trial to Combine Technologies from Tandem... Nov 12 2016
DexCom, Inc. (Nasdaq: DXCM) to Ring The Nasdaq Stock Market Opening Bell Nov 11 2016
Dexcom and Major League Soccer AT&T Rookie of the Year Jordan Morris Kick-off Partnership to Help... Nov 10 2016
DexCom (DXCM) Incurs Wider Loss in Q3, Beats on Revenue Nov 10 2016
NIH-funded International Diabetes Closed Loop (IDCL) Trial to Combine Technologies from Tandem... Nov 10 2016
DEXCOM INC Financials Nov 05 2016
ETF’s with exposure to DexCom, Inc. : November 4, 2016 Nov 04 2016
DexCom, Inc. :DXCM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 3, 2016 Nov 03 2016
Edited Transcript of DXCM earnings conference call or presentation 1-Nov-16 8:30pm GMT Nov 02 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)